HPV vaccine recommendations

Michael T. Brady, Carrie L. Byington, H. Dele Davies, Kathryn M. Edwards, Mary P. Glode, Mary Anne Jackson, Harry L. Keyserling, Yvonne A. Maldonado, Dennis L Murray, Walter A. Orenstein, Gordon E. Schutze, Rodney E. Willoughby, Theoklis E. Zaoutis

Research output: Contribution to journalReview article

69 Scopus citations

Abstract

On October 25, 2011, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommended that the quadrivalent human papillomavirus vaccine (Gardasil; Merck & Co, Inc, Whitehouse Station, NJ) be used routinely in males. The American Academy of Pediatrics has reviewed updated data provided by the Advisory Committee on Immunization Practices on vaccine efficacy, safety, and cost-effectiveness as well as programmatic considerations and supports this recommendation. This revised statement updates recommendations for human papillomavirus immunization of both males and females.

Original languageEnglish (US)
Pages (from-to)602-605
Number of pages4
JournalPediatrics
Volume129
Issue number3
DOIs
StatePublished - Mar 1 2012

    Fingerprint

Keywords

  • Adolescents
  • Cancer
  • Females
  • HPV
  • Human papillomavirus
  • Immunization
  • Males
  • Vaccine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Brady, M. T., Byington, C. L., Davies, H. D., Edwards, K. M., Glode, M. P., Jackson, M. A., Keyserling, H. L., Maldonado, Y. A., Murray, D. L., Orenstein, W. A., Schutze, G. E., Willoughby, R. E., & Zaoutis, T. E. (2012). HPV vaccine recommendations. Pediatrics, 129(3), 602-605. https://doi.org/10.1542/peds.2011-3865